The global mammography market size is expected to reach USD 4.67 billion by 2030, registering a CAGR of 10.26% according to a new report by Grand View Research, Inc. The growth is mainly driven by the rising initiatives by various governments and NGOs to raise awareness about the early diagnosis of microcalcifications in breast tissue. For instance, the National Breast Cancer Screening Programme in the Netherlands, for example, was created for women aged 50 to 75. According to the program, women in this age bracket were invited for a mammogram every two years. Similarly, in Australia, women aged 50 to 74 are required to have free mammograms every 2 years as part of the government’s national screening program, Breast Screen Australia. Some other significant organizations such as the National Breast Cancer Foundation, CDC, and Breast Cancer Organization are promoting early diagnosis of mammary gland calcification. This is one of the crucial factors expected to drive market growth.
Mammography Market Report Highlights
- Digital systems dominated the product segment in 2021 owing to the wide availability of digital breast screening devices and the presence of favorable reimbursements for such devices
- Digital mammography dominated the technology segment in 2021 due to growing awareness regarding digital technology and increasing adoption of such technology for better diagnosis
- In 2021, North America dominated due to the increasing adoption of technologically advanced screening devices and the upsurging number of approvals of 3D systems
- Asia Pacific and Latin America are the two fastest-growing regional segments, because of the higher mammary gland cancer prevalence and the growing number of government campaigns to improve breast screening
Gain deeper insights on the market and receive your free copy with TOC now @: Mammography Market Report
Mammography is a medical imaging technique that uses low-dose X-rays to capture detailed images of the breast tissue. It is primarily used for breast cancer screening and detection, as it can detect small abnormalities in the breast tissue before they can be felt by a healthcare provider or the patient. Mammography is recommended for women over the age of 40 as well as those with a higher risk of breast cancer due to family history or other factors. The procedure is quick and non-invasive, with the breast being compressed briefly between two plates to obtain the images. While mammography is an effective tool for breast cancer screening, it is not infallible, and additional testing may be needed in cases where abnormalities are detected.
Latest Developments
Mammography market was experiencing a number of developments. Technological advancements in mammography equipment, including digital mammography and 3D mammography, were driving growth in the market. These advancements allowed for more accurate and efficient detection of breast cancer, reducing the need for additional testing and improving patient outcomes. Additionally, the rising incidence of breast cancer, particularly in developing countries, was fueling demand for mammography services. However, concerns about the potential risks associated with radiation exposure from mammography were a potential barrier to market growth, leading some healthcare providers to explore alternative screening methods such as ultrasound and MRI. Overall, the mammography market was expected to continue to grow in the coming years, driven by both technological advancements and increasing demand for breast cancer screening services.
Major mammography manufacturers are introducing new products and increasing the number of approved products, which is further expected to impel the demand in the coming years. For instance, in March 2018, Siemens Healthineers obtained U.S. FDA approval for its enhanced mammography platform MAMMOMAT Revelation. This platform is combined with a new InSpect specimen imaging tool as well as new HD Breast Biopsy technology for one-click targeting of affected areas. Moreover, in October 2021, iCAD, Inc. launched its latest generation of ProFound AI for 2D Mammography.
Furthermore, the use of Artificial Intelligence (AI) in 3D mammography has reduced exam time while maintaining image quality. For instance, in March 2021, iCad received USFDA approval for its ProFound AI Version 3.0 for Digital Breast Tomosynthesis (DBT) system. Compared to previous versions of the software, it provides up to a 10% enhancement in specificity performance, up to 1% improvement in sensitivity, and offers 40% faster processing. Thus, rapid FDA approval for AI-enabled 3D mammography equipment is driving market growth.
Mammography Market Insights By Region
North America dominated the global industry and is expected to exhibit a considerable growth rate over the forecast period. 48,530 cases of in situ breast carcinoma in women have been discovered, and the number of breast cancer cases is predicted to rise in the coming years. The rising incidence of breast cancer is one of the major factors driving the regional market. Asia Pacific is anticipated to witness the fastest growth. Breast cancer is the most frequent malignancy in most Asian countries regardless of race or ethnicity. The increased prevalence of breast cancer, high R&D investments in breast cancer therapies, and developments in breast imaging modalities are the primary drivers responsible for the growth. The presence of developing countries, such as China, Japan, and India, is anticipated to boost the region’s growth further.
Competitive Analysis By Major Players
The global industry is consolidated due to the presence of a few major players. These companies have a wide product portfolio, which includes breast tomosynthesis, digital mammography, computer-aided detection, and breast biopsy devices. The industry participants are actively involved in multiple strategic initiatives to maintain their position in the market. Some of the key players in the global mammography market include:
- Hologic Inc.
- Analogic Corporation,
- Canon Medical Systems Corporation,
- Fujifilm Corporation
- Siemens Healthcare
- Toshiba Medical Systems
For More Details or Sample Copy please visit link @: https://www.grandviewresearch.com/industry-analysis/mammography-market/request/rs1
Grand View Research has segmented the mammography market on the basis of product, technology, end-use, and region.
Research Methodology
We employ a comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecasts possible. We utilize a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our market estimates and forecasts are derived through simulation models. A unique model is created and customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously.
For Customized reports or Special Pricing please visit @: https://www.grandviewresearch.com/checkout/select-license/mammography-market
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S. based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Contact:
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll-Free: 1-888-202-9519
Email: [email protected]
Web: https://www.grandviewresearch.com